CDIOW Stock Financials: Financial Performance and Reports

Period	FY-2023	FY-2022	FY-2021	FY-2020
Period Ended	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Operating Revenue	$17,065.00	$950.00	$901.00	$0.00
Cost of Revenue	$111,620.00	$16,000.00	$0.00	$0.00
Gross Profit	-$94,555.00	-$15,050.00	$901.00	$0.00
Gross Profit Ratio	-5.54	-15.84	1	0
Research and Development Expenses	$145,182.00	$40,448.00	$31,468.00	$1,500.00
General & Administrative Expenses	$6.94 M	$4.40 M	$470,563.00	$591,521.00
Selling & Marketing Expenses	$158,514.00	$92,700.00	$103,318.00	$5,476.00
Selling, General & Administrative Expenses	$7.00 M	$4.49 M	$573,881.00	$596,997.00
Other Expenses	$0.00	$0.00	$0.00	$4,000.00
Operating Expenses	$7.15 M	$4.55 M	$621,349.00	$609,164.00
Cost And Expenses	$7.26 M	$4.55 M	$621,349.00	$609,164.00
Interest Income	$1,068.00	$0.00	$0.00	$0.00
Interest Expense	$6.74 M	$0.00	$0.00	$0.00
Depreciation & Amortization	$111,620.00	$16,000.00	$16,000.00	$10,667.00
EBITDA	-$7.13 M	-$4.42 M	-$604,448.00	-$598,497.00
EBITDA Ratio	-417.86	-4652.54	-670.86	0
Operating Income	-$7.24 M	-$4.55 M	-$620,448.00	-$609,164.00
Operating Income Ratio	-424.4	-4787.84	-688.62	0
Total Other Income/Expenses Net	-$1.13 M	-$112,534.00	$2.00	$4,000.00
Income Before Tax	-$8.38 M	-$4.66 M	-$620,448.00	-$605,164.00
Income Before Tax Ratio	-490.88	-4906.3	-688.62	0
Income Tax Expense	$0.00	$112,534.00	$2.00	$0.00
Net Income	-$8.38 M	-$4.66 M	-$620,448.00	-$605,164.00
Net Income Ratio	-490.88	-4906.3	-688.62	0
EPS	-0.66	-1.51	-0.53	-0.0636
EPS Diluted	-0.66	-1.51	-0.53	-0.0636
Weighted Average Shares Out	$12.69 M	$3.09 M	$1.16 M	$9.51 M
Weighted Average Shares Out Diluted	$12.69 M	$3.09 M	$1.16 M	$9.51 M
Link

Cardio Diagnostics Holdings, Inc. (CDIOW) Financials